Literature DB >> 24932755

Educational gradients in psychotropic medication use among older adults in Costa Rica and the United States.

Marisa Elena Domino, William H Dow, Fernando Coto-Yglesias.   

Abstract

OBJECTIVE: The relationship of education, psychiatric diagnoses, and use of psychotropic medication has been explored in the United States, but little is known about this relationship in poorer countries, despite the high burden of mental illness in these countries. This study estimated educational gradients in diagnosis and psychotropic drug use in the United States and Costa Rica, a middle-income country with universal health insurance.
METHODS: Analyses were conducted by using data of older adults (≥60) from the 2005 U.S. Medical Expenditure Panel Survey (N=4,788) and the 2005 Costa Rican Longevity and Healthy Aging Study (N=2,827). Logistic regressions examined the effect of education level (low, medium, or high) and urban residence on the rates of self-reported mental health diagnoses, screening diagnosis, and psychotropic medication use with and without an associated psychiatric diagnosis.
RESULTS: Rates of self-reported diagnoses were lower in the United States (12%) than in Costa Rica (20%), possibly reflecting differences in survey wording. In both countries, the odds of having depression were significantly lower among persons with high education. In Costa Rica, use of psychotropic medication among persons with self-reported diagnoses increased by education level.
CONCLUSIONS: The educational gradients in medication use were different in the United States and Costa Rica, and stigma and access to care in these countries may play an important role in these differences, although type of insurance did not affect educational gradients in the United States. These analyses increase the evidence of the role of education in use of the health care system.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24932755      PMCID: PMC4183704          DOI: 10.1176/appi.ps.201300092

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  18 in total

1.  Disease and disadvantage in the United States and in England.

Authors:  James Banks; Michael Marmot; Zoe Oldfield; James P Smith
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

2.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  Off-label prescribing among office-based physicians.

Authors:  David C Radley; Stan N Finkelstein; Randall S Stafford
Journal:  Arch Intern Med       Date:  2006-05-08

4.  Recovery from depression, work productivity, and health care costs among primary care patients.

Authors:  G E Simon; D Revicki; J Heiligenstein; L Grothaus; M VonKorff; W J Katon; T R Hylan
Journal:  Gen Hosp Psychiatry       Date:  2000 May-Jun       Impact factor: 3.238

5.  Validity of the Patient Health Questionnaire 2 (PHQ-2) in identifying major depression in older people.

Authors:  Chunyu Li; Bruce Friedman; Yeates Conwell; Kevin Fiscella
Journal:  J Am Geriatr Soc       Date:  2007-04       Impact factor: 5.562

6.  Spatial access to health care in Costa Rica and its equity: a GIS-based study.

Authors:  Luis Rosero-Bixby
Journal:  Soc Sci Med       Date:  2004-04       Impact factor: 4.634

7.  Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication.

Authors:  Benjamin G Druss; Philip S Wang; Nancy A Sampson; Mark Olfson; Harold A Pincus; Kenneth B Wells; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2007-10

8.  The Patient Health Questionnaire-2: validity of a two-item depression screener.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams
Journal:  Med Care       Date:  2003-11       Impact factor: 2.983

Review 9.  Depression in later life: a diagnostic and therapeutic challenge.

Authors:  Richard B Birrer; Sathya P Vemuri
Journal:  Am Fam Physician       Date:  2004-05-15       Impact factor: 3.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.